Corporate News – Alpha Tau Medical (DRTS)
Trading Summary
- Last 24‑hour change: +2.02 %
- Closing time: 06:38 AM Central Europe, Monday 26 th
- Current share price: USD 13.16 (traded on popular exchanges)
- Shares outstanding: 92.7 million
- Market capitalization: USD 1.2 billion
- Volume (last 24 h): USD 4.3 million worth of shares traded
Historical Performance
- Month‑end change: –10.9 % since the end of the previous month
- 200‑day simple moving average: USD 10.44
- 52‑week high: USD 15.79 (recorded 17 September 2026)
- 52‑week low: USD 3.43 (recorded 21 November 2025)
Related Stocks – 24‑hour Performance
| Symbol | % Change | Current Price | Market Cap | Additional Ratios |
|---|---|---|---|---|
| PLTK | +0.24 % | USD 2.07 | USD 787.6 million | — |
| INMD | –0.57 % | USD 13.97 | USD 803 million | P/E = 11.53 |
| CGNT | +5.23 % | USD 9.76 | USD 720.7 million | — |
| RDWR | +4.33 % | USD 31.07 | USD 1.3 billion | P/E = 79.42 |
| RSKD | +2.58 % | USD 9.15 | USD 1.2 billion | — |
Company Profile
Alpha Tau Medical Ltd. is headquartered in Wilmington, Delaware, USA, and is listed on the Nasdaq stock exchange. The company focuses on the development and manufacturing of medical devices, specifically diffusing alpha‑emitter radiation therapy for conformal treatment of solid tumors. Its products and services are delivered globally. More detailed information can be found on the company’s website at www.alphatau.com .
